Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation

• Published in: Experimental cell research 2006-06, Vol.312 (10), p.1909-1923
• Main Authors: Nguyen, Aaron N., Stebbins, Elizabeth G., Henson, Margaret, O'Young, Gilbert, Choi, Sun J., Quon, Diana, Damm, Debby, Reddy, Mamatha, Ma, Jing Y., Haghnazari, Edwin, Kapoun, Ann M., Medicherla, Satyanarayana, Protter, Andy, Schreiner, George F., Kurihara, Noriyoshi, Anderson, Judy, Roodman, G. David, Navas, Tony A., Higgins, Linda S.
• Format: Article
• Language: English
• Subjects: 60 APPLIED LIFE SCIENCES; Animals; BONE MARROW; Bone Marrow - chemistry; Bone Marrow - metabolism; Bone marrow microenvironment; Carrier Proteins - metabolism; CCL8; Cell adhesion; Cell Adhesion - physiology; CELL PROLIFERATION; Chemokines; Chemokines - metabolism; Coculture Techniques; Culture Media, Conditioned; CXCL10; Humans; IL-6; IN VITRO; Indoles - metabolism; Interleukin-6 - secretion; Membrane Glycoproteins - metabolism; Multiple Myeloma - metabolism; Multiple Myeloma - pathology; NEOPLASMS; Oligonucleotide Array Sequence Analysis; Osteoclast formation; Osteoclasts - cytology; Osteoclasts - physiology; p38 MAPK inhibitor; p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors; p38 Mitogen-Activated Protein Kinases - metabolism; PROTEINS; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; REDUCTION; SCIO-469; SECRETION; Stromal Cells - cytology; Stromal Cells - metabolism; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha - metabolism; Vascular Endothelial Growth Factor A - secretion; VEGF
• ISSN: 0014-4827; 1090-2422
• DOI: 10.1016/j.yexcr.2006.02.026

The multiple myeloma (MM) bone marrow (BM) microenvironment plays a critical role in supporting tumor growth and survival as well as in promoting formation of osteolytic lesions. Recent results suggest that the p38 mitogen-activated protein kinase (MAPK) is an important factor in maintaining this activated environment. In this report, we demonstrate that the p38α MAPK inhibitor, SCIO-469, suppresses secretion of the tumor-supportive factors IL-6 and VEGF from BM stromal cells (BMSCs) as well as cocultures of BMSCs with MM cells, resulting in reduction in MM cell proliferation. Additionally, we show that SCIO-469 prevents TNFα-induced adhesion of MM cells to BMSCs through an ICAM-1- and VCAM-1-independent mechanism. Microarray analysis revealed a novel set of TNFα-induced chemokines in BMSCs that is strongly inhibited by SCIO-469. Furthermore, reintroduction of chemokines CXCL10 and CCL8 to BMSCs overcomes the inhibitory effect of SCIO-469 on TNFα-induced MM adhesion. Lastly, we show that SCIO-469 inhibits secretion and expression of the osteoclast-activating factors IL-11, RANKL, and MIP-1α as well as prevents human osteoclast formation in vitro. Collectively, these results suggest that SCIO-469 treatment can suppress factors in the bone marrow microenvironment to inhibit MM cell proliferation and adhesion and also to alleviate osteolytic activation in MM.